News Center

• DCP Capital Closes Their Debut PE Fund with US$2.5 Billion of Total Commitments

  Beijing, Hong Kong – April 16, 2019 – DCP Capital (“DCP”), a leading international private equity investment firm, today announced the final closing of the firm’s first Greater China focused US dollar private equity fund, DCP Capital Partners I (the “Fund”), which closed at its cap of over US$2 billion in commitments.

  2019-04-16

• Ex-KKR China Heads Said to Raise $2 Billion for New Fund

  KKR & Co.’s former China heads have raised $2 billion for their debut private equity fund, according to people familiar with the matter. DCP Capital has committed 30 percent of the money for six deals in China, and the firm has also raised $500 million for a fund denominated in yuan that focuses on domestic Chinese investments.

  2019-04-16

• David Liu: Hailed by Wu Shangzhi as "the most astute PE investor in China"

  KKR made an announcement that shocked the market yesterday. It said that David Liu, partner at KKR, Co-head of KKR Asia Private Equity, and CEO of KKR Greater China, has resigned. Together with another partner, Julian Wolhardt, the two will set up their own private equity firm.

  2016-08-31

• DCP Capital invests $120m in Sunpower Group

  DCP Capital, a private equity firm focusing on China, on Tuesday announced investment of $120 million through two rounds of convertible bonds to fuel the further growth of Sunpower Group Limited.

  2018-09-12

• DCP’s Investment in Sunpower Group

  DCP Capital (“DCP”) today announced that it has invested a total of USD$120 million through 2 rounds of Convertible Bonds to support the continued growth of Sunpower Group Limited (“Sunpower” or the “Company”) (SGX: 5GD.SI).

  2018-09-11

• DCP Capital Announces Equity Investment in Venus Medtech

  DCP Capital (“DCP”) announced that it has reached a definitive agreement with Venus Medtech for an equity investment. The investment will facilitate Venus Medtech’s buildout of its sales network to establish the leading position in China’s transcatheter aortic valve replacement (TAVR) market.

  2018-05-16